Maverick Advocaten assisted GIMV with the transaction. GIMV obtained approval from the ACM for its investment in Variass. GIMV is a European investment company that focuses on investing...
GIMV’s Investment in Variass
UMCG’s Entry as a New Shareholder in GenomeScan
Maverick Advocaten assisted academic hospitals Erasmus MC, LUMC, UMCG and GenomeScan in the transaction. Academic hospitals Erasmus MC, LUMC, UMCG and GenomeScan obtained approval from the NZa...